A detailed history of Spire Wealth Management transactions in Precigen, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 1,398 shares of PGEN stock, worth $964. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,398
Previous 1,400 0.14%
Holding current value
$964
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$0.91 - $1.88 $1 - $3
-2 Reduced 0.14%
1,398 $1,000
Q3 2022

Nov 07, 2022

BUY
$1.41 - $2.79 $846 - $1,674
600 Added 75.0%
1,400 $3,000
Q2 2021

Jul 26, 2021

SELL
$6.24 - $8.22 $1,248 - $1,644
-200 Reduced 20.0%
800 $5,000
Q1 2021

May 21, 2021

BUY
$6.74 - $10.95 $6,740 - $10,950
1,000 New
1,000 $7,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $144M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.